Yazar "Basturk, A." seçeneğine göre listele
Listeleniyor 1 - 13 / 13
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe BLASTIC INFILTRATION OF THE CENTRAL NERVOUS SYSTEM IN A PATIENT WITH CHRONIC MYELOID LEUKEMIA(PERGAMON-ELSEVIER SCIENCE LTD, 2015) Dagli, M.; Kutlucan, A.; Kutlucan, L.; Basturk, A.; Ugurluoglu, C.; Sozen, M.; Turkay, K.[Abstract not Available]Öğe CAN LEUKOCYTE SUBGROUPS OF CRITICAL PATIENTS BE AN INDICATOR FOR MORTALITY, DURATION OF HOSPITALISATION AND DEVELOPMENT OF HOSPITAL INFECTION?(PERGAMON-ELSEVIER SCIENCE LTD, 2015) Kutlucan, L.; Kutlucan, A.; Basturk, A.; Basaran, B.; Kozanhan, B.; Gur, M.; Senocak, E.[Abstract not Available]Öğe A CASE OF NEUTROPENIA DUE TO ACUTE EXPOSURE WITH ALUMINUM PHOSPHIDE(PERGAMON-ELSEVIER SCIENCE LTD, 2014) Dagli, M.; Basturk, A.; Kutlucan, L.; Copur, B.; Kutlucan, A.; Colkesen, F.[Abstract not Available]Öğe CLINICAL IMPORTANCE OF B2 GLYCOPROTEIN I ANTIBODIES IN BCR-ABL NEGATIVE MYELOPROLIFERATIVE NEOPLASMS(FERRATA STORTI FOUNDATION, 2016) Kocak, M. Z.; Dagli, M.; Kutlucan, A.; Basturk, A.; Unlu, A.; Acar, H.; Kutlucan, L.[Abstract not Available]Öğe COINCIDENCE OF AUTUIMMUNE HEMOLYTIC ANEMIA AND AUTOIMMUNE HEPATITIS(PERGAMON-ELSEVIER SCIENCE LTD, 2015) Kutlucan, A.; Dagli, M.; Kutlucan, L.; Ermis, F.; Basturk, A.; Ugurluoglu, C.; Sozen, M.[Abstract not Available]Öğe COMPARISON OF PULSE WITH HIGH DOSE STEROID TREATMENT IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA(PERGAMON-ELSEVIER SCIENCE LTD, 2014) Dagli, M.; Kutlucan, L.; Basturk, A.; Kutlucan, A.; Copur, B.[Abstract not Available]Öğe THE EFFECT OF ANEMIA AND RED CELL TRANSFUSIONS ON MORTALITY IN YOUNG AND ELDERLY INTENSIVE CARE PATIENTS WITH NOSOCOMIAL INFECTION(PERGAMON-ELSEVIER SCIENCE LTD, 2014) Kutlucan, L.; Kutlucan, A.; Kandis, H.; Titiz, H.; Senocak, E.; Basturk, A.; Dagli, M.[Abstract not Available]Öğe THE IMPORTANCE OF HIGH PLATELET-LYMPHOCYTE RATIO ON PROGNOSIS, DURATION OF HOSPITALISATION AND DEVELOPMENT OF HOSPITAL INFECTION AMONG INTENSIVE CARE PATIENTS(PERGAMON-ELSEVIER SCIENCE LTD, 2015) Kutlucan, L.; Kutlucan, A.; Basturk, A.; Gur, M.; Senocak, E.[Abstract not Available]Öğe PARAVERTEBRAL EXTRAMEDULLARY HEMATOPOIESIS IN A PATIENT WITH THALASSEMIA INTERMEDIA(PERGAMON-ELSEVIER SCIENCE LTD, 2017) Kutlucan, A.; Dagli, M.; Kutlucan, L.; Kuku, M.; Basturk, A.[Abstract not Available]Öğe The predictive effect of initial complete blood count of intensive care unit patients on mortality, length of hospitalization, and nosocomial infections(VERDUCI PUBLISHER, 2016) Kutlucan, L.; Kutlucan, A.; Basaran, B.; Dagli, M.; Basturk, A.; Kozanhan, B.; Gur, M.OBJECTIVE: The mean platelet volume (MPV) can be used as an indicator of platelet activation. However, it has been shown that the platelet/lymphocyte ratio (PLR) can provide useful predictive information about inflammation and aggregation pathways. The neutrophil/lymphocyte ratio (NLR) may also be helpful as a marker of systemic or local inflammation. The main objective of this study evaluated to unselected critically ill patients the relationship of initial MPV, NLR, and PLR with mortality, length of hospitalization, and the risk of developing nosocomial infections in ICU patients. PATIENTS AND METHODS: In this retrospective study, we evaluated consecutive patients at our tertiary nine-bed ICU. One hundred seventy-three patients who were followed up during a 1-year period were included. RESULTS: MPV levels were found to be higher in patients who died in the hospital (p = 0.05). In addition, there was a significant positive correlation between expected mortality rate and MPV among non-survivors (p = 0.009). NLR levels were higher among non-survivors, but this difference was not statistically significant (p = 0.435). PLR levels were similar between non-survivors and survivors (p = 0.173). The initial NLR and PLR were significantly higher in patients with nosocomial infections. NLR and PLR had a significant positive correlation with length of hospitalization (p = 0.006 and p = 0.027, respectively). CONCLUSIONS: In our study, we found that high PLR and NLR may be indicators for the development of nosocomial infections. Moreover, the length of hospitalization may be prolonged in patients with high PLR and NLR.Öğe SECONDARY ACUTE LYMPYHOBLASTIC LEUKEMIA DEVELOPED AFTER REFRACTORY LEIOMYOSARCOMA(PERGAMON-ELSEVIER SCIENCE LTD, 2017) Kutlucan, A.; Kutlucan, L.; Basturk, A.; Dagli, M.; Tras, G.[Abstract not Available]Öğe SEVERE RENAL FAILURE DUE TO HIGH DOSE METHOTREXATE IN ACUTE LYMPHOBLASTIC LEUKEMIA ASSOCIATED WITH PREDISPOSING FACTORS: CASE REPORT(PERGAMON-ELSEVIER SCIENCE LTD, 2014) Dagli, M.; Basturk, A.; Kutlucan, L.; Copur, B.; Kutlucan, A.; Sahin, F.[Abstract not Available]Öğe THYROZINE KINASE INHIBITORS IN CENTRAL NERVOUS SYSTEM RELAPSE OF A CHRONIC MYELOID LEUKEMIA: A CASE REPORT(PERGAMON-ELSEVIER SCIENCE LTD, 2017) Dagli, M.; Basturk, A.; Kutlucan, A.; Kutlucan, L.[Abstract not Available]
